Schiller, Lowy, President Obama, and military aide holding medal at ceremony.
Tuesday, December 23, 2014

Two NCI scientists received the National Medal of Technology and Innovation, the nation’s highest honor for technological achievement. The award was announced by President Obama in October. The honorees, John Schiller, Ph.D., Laboratory of Cellular Oncology (LCO), Center for Cancer Research, NCI, and Douglas Lowy, M.D., also from LCO and NCI deputy director, received their medals at a White House ceremony on Nov. 20.

Employees browsing vendor tables at Holiday Market
Wednesday, December 17, 2014

By Carolynne Keenan, Contributing Writer

If you are still looking for the “perfect” gift, mark your calendar for the Holiday Market.

The December Holiday Market is set for Tuesday, Dec. 23, in Building 549, from 10:30 a.m. to 2 p.m. (or until vendors sell out).

Three scientists at award presentation.
Wednesday, December 10, 2014

By Anne Arthur, Guest Writer

The Third Annual David Derse Memorial Lecture and Award presentation was held on Nov. 18 at NCI at Frederick to honor the outstanding research accomplishments of David Derse, Ph.D., and to stimulate the exchange of innovative ideas that Derse was well known for promoting throughout his scientific career.

Tuesday, December 9, 2014

Platinum Publications are selected from articles by NCI at Frederick scientists published in 42 prestigious science journals. This list represents articles published during the time period shown above, as generated from PubMed.

Articles designated as Platinum Highlights are noteworthy articles selected by Dr. Craig Reynolds, associate director, National Cancer Institute, from among the most recently published Platinum Publications.

Two scientists in the lab. Doctor Cho is on left and Doctor Daar is on right.
Tuesday, December 9, 2014

Platinum Highlight Icon

By Nancy Parrish, Staff Writer

The family of proteins known as ephrins plays a critical role in a variety of biological processes. In a recent article in the Journal of Biological Chemistry, Hee Jun Cho, Ph.D., and colleagues report on the interaction between proteins CNK1 and ephrinB1 that promotes cell movement. Their findings may have an important implication in developing new therapeutics for reducing metastases in certain cancers.

“Eph and ephrin signaling has become an area of intense interest due to the influence these molecules exert on the control of cell adhesion and cell movement,” Cho said. “This signaling affects the formation of tissues during development and has been shown to play an instructive role in angiogenesis, as well as tumor cell invasion.”

Pages